412
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Calprotectin — A Marker of Mortality in COPD? Results from a Prospective Cohort Study

, , , , , & show all
Pages 581-587 | Published online: 11 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Markus Niemelä, Onni Niemelä, Risto Bloigu, Aini Bloigu, Päivikki Kangastupa & Tatu Juvonen. (2020) Serum Calprotectin, a Marker of Neutrophil Activation, and Other Mediators of Inflammation in Response to Various Types of Extreme Physical Exertion in Healthy Volunteers. Journal of Inflammation Research 13, pages 223-231.
Read now
Arne Åsberg, Lena Løfblad, Amela Felic & Gunhild Garmo Hov. (2019) Measuring calprotectin in plasma and blood with a fully automated turbidimetric assay. Scandinavian Journal of Clinical and Laboratory Investigation 79:1-2, pages 50-57.
Read now
Konstantinos Kostikas, Stelios Loukides & Petros Bakakos. (2013) Biomarkers in COPD: Is Mortality the Holy Grail?. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:5, pages 557-559.
Read now

Articles from other publishers (8)

Onni Niemelä. 2023. Advances In Clinical Chemistry. Advances In Clinical Chemistry 113 181 .
Onni Niemelä, Anni Halkola, Aini Bloigu, Risto Bloigu, Ulla Nivukoski, Heidi Pohjasniemi & Johanna Kultti. (2022) Blood Cell Responses Following Heavy Alcohol Consumption Coincide with Changes in Acute Phase Reactants of Inflammation, Indices of Hemolysis and Immune Responses to Ethanol Metabolites. International Journal of Molecular Sciences 23:21, pages 12738.
Crossref
Richard Y. Kim, Krishna P. Sunkara, Ken R. Bracke, Andrew G. JarnickiChantal Donovan, Alan C. Hsu, Antonio IeniEmma L. Beckett, Izabela Galvão, Sara WijnantFabio LM. Ricciardolo, Antonino Di Stefano, Tatt Jhong Haw, Gang Liu, Angela L. Ferguson, Umamainthan Palendira, Peter A. Wark, Griet Conickx, Pieter Mestdagh, Guy G. Brusselle, Gaetano Caramori, Paul S. Foster, Jay C. HorvatPhilip M. Hansbro. (2021) A microRNA-21–mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis. Science Translational Medicine 13:621.
Crossref
Ulla Nivukoski, Aini Bloigu, Risto Bloigu, Johanna Kultti, Heidi Tuomi & Onni Niemelä. (2021) Comparison of serum calprotectin, a marker of neutrophil activation, and other mediators of inflammation in response to alcohol consumption. Alcohol 95, pages 45-50.
Crossref
Ourania S. Kotsiou, Dimitrios Papagiannis, Rodanthi Papadopoulou & Konstantinos I. Gourgoulianis. (2021) Calprotectin in Lung Diseases. International Journal of Molecular Sciences 22:4, pages 1706.
Crossref
Laura Martos, Julia Oto, Álvaro Fernández-Pardo, Emma Plana, María José Solmoirago, Fernando Cana, David Hervás, Santiago Bonanad, Fernando Ferrando, Francisco España, Silvia Navarro & Pilar Medina. (2020) Increase of Neutrophil Activation Markers in Venous Thrombosis—Contribution of Circulating Activated Protein C. International Journal of Molecular Sciences 21:16, pages 5651.
Crossref
Allan Klitgaard Sørensen, Dennis Back Holmgaard, Lone Hagens Mygind, Julia Johansen & Court Pedersen. (2015) Neutrophil-to-lymphocyte ratio, calprotectin and YKL-40 in patients with chronic obstructive pulmonary disease: correlations and 5-year mortality – a cohort study. Journal of Inflammation 12:1.
Crossref
Richard E. Russell. (2014) Chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 20:2, pages 127-131.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.